Medical Design and Outsourcing reports that AliveCor’s smartphone app matches the accuracy of a standard 12-lead ECG in monitoring heart activity and determining if someone is having an ST-segment elevation myocardial infarction (STEMI). Led by Salt Lake City, Utah’s Intermountain Medical Center Heart Institute, the researcher’s followed 204 patients with chest pain who received both a standard 12-lead ECG and an ECG through AliveCor’s app.
AliveCor privately held, was formed in 2011 and is a medical device and artificial intelligence company that sells ECG hardware and software for consumer mobile devices. The company is the first to receive FDA-clearance for a medical-device accessory to the Apple Watch.
Brent Muhlestein, M.D., co-director of cardiology research, Intermountain Health Care